IMA Advisory Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EP
IA
IMA Advisory Services's AZN Position: Q2 2026 in Review
IMA Advisory Services increased its AstraZeneca (AZN) stake by 244% in Q2 2026, buying an estimated $232K and bringing the position to 1,743 shares worth $331K. The position accounts for 0.02% of the portfolio, ranked #276.
IMA Advisory Services first reported a position in AZN in Q3 2024 and has held it in 7 quarters since. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- IMA Advisory Services held 1,743 shares of AstraZeneca worth $331K as of Q2 2026.
- IMA Advisory Services bought 1,236 AstraZeneca shares in Q2 2026, an estimated $232K.
- AstraZeneca made up 0.02% of IMA Advisory Services's portfolio in Q2 2026, its #276 holding.
- IMA Advisory Services first reported a position in AstraZeneca in Q3 2024 and has held it in 7 quarters since.
- 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on IMA Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.